The price of Hims & Hers Health Inc (NYSE:HIMS) shares last traded on Wall Street rose 1.64% to $16.73.
HIMS stock price is now -16.88% away from the 50-day moving average and 20.30% away from the 200-day moving average. The market capitalization of the company currently stands at $3.63B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $24, Needham recently initiated with Buy rating for Hims & Hers Health Inc (NYSE: HIMS). , while ‘Citigroup’ rates the stock as ‘Neutral’
In other news, Boughton Soleil, Chief Legal Officer sold 2,334 shares of the company’s stock on Aug 20 ’24. The stock was sold for $39,001 at an average price of $16.71. Upon completion of the transaction, the Chief Legal Officer now directly owns 162,141 shares in the company, valued at $2.71 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 20 ’24, Officer Boughton Soleil bought 2,334 shares of the business’s stock. A total of $39,001 was incurred on buying the stock at an average price of $16.71. A total of 24.41% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $5.65 and a high of $25.74. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 2.68, and a quick ratio of 2.30. The fifty day moving average price for HIMS is $19.9892 and a two-hundred day moving average price translates $13.95865 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for 2024-06-30. The net profit margin was 1.70% and return on equity was 5.31% for HIMS. The company reported revenue of $315.65 million for the quarter, compared to $207.91 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 51.82 percent. For the current quarter, analysts expect HIMS to generate $378.45M in revenue.
